Incretin Mimetics: Promising New Therapeutic Options in the Treatment of Type 2 Diabetes

OBJECTIVES: To review the current state of diabetes treatment from a clinical and management perspective and explore the role that new biologic pharmaceuticals may offer patients who fail to meet or maintain glycemic goals with existing treatment options. SUMMARY: Key clinical areas involve the role...

Descripción completa

Detalles Bibliográficos
Autores principales: Gleeson, Jeremy M., Berenbeim, David M., Gilkin, Robert J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2005
Materias:
Supplement
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437539/
https://www.ncbi.nlm.nih.gov/pubmed/16137221
http://dx.doi.org/10.18553/jmcp.2005.11.s7.1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10437539/
https://www.ncbi.nlm.nih.gov/pubmed/16137221
http://dx.doi.org/10.18553/jmcp.2005.11.s7.1

Ejemplares similares